Amgen has announced plans to invest over $600 million to build a state-of-the-art center for science and innovation at its Thousand Oaks global headquarters. The facility will consolidate cross-disciplinary teams and integrate advanced automation and digital tools to accelerate next-generation therapeutic discovery. Construction is expected to begin in Q3 2025, creating hundreds of U.S. jobs and complementing Amgen's recent investments in U.S.-based manufacturing and R&D expansion.